1. Home
  2. CAAS vs ASMB Comparison

CAAS vs ASMB Comparison

Compare CAAS & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAAS
  • ASMB
  • Stock Information
  • Founded
  • CAAS N/A
  • ASMB 2005
  • Country
  • CAAS China
  • ASMB United States
  • Employees
  • CAAS N/A
  • ASMB N/A
  • Industry
  • CAAS Auto Parts:O.E.M.
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAAS Consumer Discretionary
  • ASMB Health Care
  • Exchange
  • CAAS Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • CAAS 130.9M
  • ASMB 141.8M
  • IPO Year
  • CAAS N/A
  • ASMB 2010
  • Fundamental
  • Price
  • CAAS $4.10
  • ASMB $26.93
  • Analyst Decision
  • CAAS
  • ASMB Strong Buy
  • Analyst Count
  • CAAS 0
  • ASMB 4
  • Target Price
  • CAAS N/A
  • ASMB $38.67
  • AVG Volume (30 Days)
  • CAAS 35.0K
  • ASMB 126.9K
  • Earning Date
  • CAAS 08-13-2025
  • ASMB 08-06-2025
  • Dividend Yield
  • CAAS N/A
  • ASMB N/A
  • EPS Growth
  • CAAS N/A
  • ASMB N/A
  • EPS
  • CAAS 0.97
  • ASMB N/A
  • Revenue
  • CAAS $696,272,000.00
  • ASMB $33,247,000.00
  • Revenue This Year
  • CAAS N/A
  • ASMB $0.04
  • Revenue Next Year
  • CAAS N/A
  • ASMB N/A
  • P/E Ratio
  • CAAS $4.23
  • ASMB N/A
  • Revenue Growth
  • CAAS 17.08
  • ASMB 54.77
  • 52 Week Low
  • CAAS $3.42
  • ASMB $7.75
  • 52 Week High
  • CAAS $5.37
  • ASMB $27.17
  • Technical
  • Relative Strength Index (RSI)
  • CAAS 50.67
  • ASMB 79.31
  • Support Level
  • CAAS $4.01
  • ASMB $24.80
  • Resistance Level
  • CAAS $4.15
  • ASMB $26.24
  • Average True Range (ATR)
  • CAAS 0.16
  • ASMB 1.39
  • MACD
  • CAAS 0.01
  • ASMB 0.37
  • Stochastic Oscillator
  • CAAS 57.14
  • ASMB 97.23

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: